ArticleJournal of family medicine and primary care2025
Diabetic retinopathy and dyslipidemia among patients with type 2 diabetes mellitus in the Jazan endocrine and diabetes center: A case-control study.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic retinopathy (DR) is a well-known complication of diabetes mellitus (DM) that requires early diagnosis and treatment. The major risk factors for DR include older age, dyslipidemia, obesity, and higher levels of glycated hemoglobin. This study aimed to assess the type and severity of DR in type 2 patients and its correlation with dyslipidemia in Jazan, Saudi Arabia. Methods: This case-control study was conducted at the Jazan endocrine and diabetes center. The study included type 2 diabetic patients without DR as controls and type 2 diabetic patients with DR as cases. Version 26 of SPSS was used to analyze the data, and multivariate analysis was performed to identify the risk factors for DR. Results: The study included 210 patients as controls and 100 patients as cases; mild nonproliferative DR was the most common degree (52%), and 5% had maculopathy. The comparison between the two groups revealed that there was no significant difference regarding experiencing dyslipidemia ( Conclusion: Mild nonproliferative DR was the most dominant DR among Saudi T2DM patients. Neither dyslipidemia nor serum lipid was associated with developing DR. However, the administration of statin, older age, and a combination of insulin and oral hyperglycemics were significant risk factors for DR among T2DM patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.